Skip to main content
Clinical Trials/NCT03568981
NCT03568981
Unknown
Not Applicable

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

Yonsei University1 site in 1 country200 target enrollmentApril 11, 2018
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Yonsei University
Enrollment
200
Locations
1
Primary Endpoint
Change of patient reported psychosocial functioning score
Last Updated
7 years ago

Overview

Brief Summary

This study aim to investigate the effect of 5-fraction stereotactic partial breast irradiation and whole breast irradiation on patient-reported outcomes, cosmetic outcome, and breast tissue fibrosis in early-stage breast cancer.

Registry
clinicaltrials.gov
Start Date
April 11, 2018
End Date
April 11, 2023
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pathologically confirmed invasive breast carcinoma or ductal carcinoma in situ (DCIS)
  • Women who underwent breast-conservating surgery and have a plan to undergoing partial or whole breast irradiation
  • Good performance status (ECOG 0-1)

Exclusion Criteria

  • Recurrent breast cancer
  • History of ipsilateral breast irradiation
  • Positive resection margin status after breast surgery

Outcomes

Primary Outcomes

Change of patient reported psychosocial functioning score

Time Frame: 2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported psychosocial functioning measured in 7 point Likert scale

Change of patient reported patient treatment satisfaction score

Time Frame: 2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported patient treatment satisfaction measured in 7 point Likert scale

Change of patient reported physical functioning score

Time Frame: 2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported physical functioning measured in 7 point Likert scale

Change of patient reported body image score

Time Frame: 2 year after radiotherapy (allowed to plus 8 weeks)

Patient reported body image score measured in 7 point Likert scale

Change of breast cosmesis measures (excellent/good/poor)

Time Frame: 2 year after radiotherapy (allowed to plus 8 weeks)

breast cosmesis result is measures by BCCT.core (Breast Cancer Conservative Treatment cosmetic results) software

Change of breast-tissue fibrosis measures (gram)

Time Frame: 2 year after radiotherapy (allowed to plus 8 weeks)

breast-tissue fibrosis is measured by tissue compliance meter device.

Secondary Outcomes

  • Incidence of Radiotherapy-related complications(2 year after radiotherapy (allowed to plus 8 weeks))

Study Sites (1)

Loading locations...

Similar Trials